Profile
Karl Hsu worked as Senior Vice President-Clinical Development at Acrivon Therapeutics, Inc. from 2023 to 2024.
Previously, Dr. Hsu was SVP-Clinical Research & Early Development at Zai Lab Ltd.
Former positions of Karl Hsu
| Companies | Position | End |
|---|---|---|
| ACRIVON THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2024-01-01 |
| ZAI LAB LIMITED | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Zai Lab Ltd.
Zai Lab Ltd. BiotechnologyHealth Technology Develops medicine for cancer, autoimmune and infectious diseases | Health Technology |
Acrivon Therapeutics, Inc.
Acrivon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and sells precision oncology medicines | Health Technology |
- Stock Market
- Insiders
- Karl Hsu
















